&nbsp;

Nov 2024

Drug

tremelimumab

Other Name(s): Imjudo®

Quick Link(s):

Apr 2024

Drug

carfilzomib

Other Name(s): Kyprolis®

Quick Link(s):

Feb 2024

Drug

trastuzumab

Other Name(s): Herceptin® , Kanjinti™; Ogivri™; Trazimera™; Herzuma®; Ontruzant®

Quick Link(s):

Dec 2024

Guidelines and Advice

Endometrial Cancer Molecular Testing Recommendations Report

Status: Current
Version: 1

Nov 2024

Drug

bevacizumab

Other Name(s): Avastin® , Mvasi®; Zirabev®; Bambevi®; Abevmy®; Aybintio®; Vegzelma™

Quick Link(s):

Nov 2024

Drug

isatuximab

Other Name(s): Sarclisa®

Quick Link(s):

Mar 2024

Drug

nab-PACLitaxel

Other Name(s): Abraxane®

Quick Link(s):

Dec 2024

Drug

bortezomib

Other Name(s): Velcade®

Quick Link(s):

Nov 2024

Regimen

CRBPETOP+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

, Collapse Show fewer tags

Drugs Used:

atezolizumab,

atezolizumab (subcut),

CARBOplatin,

etoposide

... Show more tags

Quick Link(s):

Regimen Monograph

May 2025

Regimen

CRBPETOP(PO)+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer